Delivery Order SPE2DB24D3013-SPE2DB25FFJUT

Award Date 2/26/25
Potential Completion Date 2/27/25
Potential Value $3.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $15,640.62 and a completion date of May 8, 2024. It is a firm fixed-price contract, without any set-aside designation. AmerisourceBergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML medication. The contract has a ceiling value of $1,942.29 and runs through February 27, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $1,854.36 and a period of performance through July 10, 2024. The contract is a firm fixed-price delivery order and was not set aside for any specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 15 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $16,558.01 and a period of performance through January 13, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $2,720.90 and a period of performance through January 27, 2025. This contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition....
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a large pharmaceutical distributor, for the supply of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a specialty medication. The contract has a ceiling value of $9,344.21 and runs through December 27, 2024. The contract is a Firm Fixed Price arrangement, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $45,832.26 and a period of performance through July 29, 2024. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, and has a ceiling value of $15,836.78. The contract is a firm fixed-price delivery order that runs through January 2, 2025. AmerisourceBergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $6,117.18 and an ultimate completion date of May 20, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, to support military healthcare programs. The contract has a ceiling value of $1,088.36 and runs through February 10, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
  • SPE2DB24D3013
    Indefinite Delivery Contract
  • SPE2DB24D3013-SPE2DB25FFJUT
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for MOUNJARO 12.5 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $3,809.26 and a period of performance through February 27, 2025. The contract is a firm fixed price delivery order, with no set-aside requirements indicated. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as the primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 5/28/25, 11:00 AM